15 results
Pneumonia Severity Criteria - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_

#Pneumonia #Severity #Criteria #IDSA2019 #Guidelines #Inpatient #HAP
Severity Criteria - IDSA ... 2019 Guidelines ... Criteria #IDSA2019 #Guidelines ... #Inpatient #HAP ... #HCAP #Treatment
Inpatient Pnuemonia Management Algorithm - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_/

#Pneumonia #Management #Algorithm #IDSA2019 #Guidelines #Inpatient
Management Algorithm - IDSA ... 2019 Guidelines ... Algorithm #IDSA2019 #Guidelines ... #Inpatient #HAP ... #HCAP #Treatment
Inpatient Pnuemonia Management Algorithm - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_

#Pneumonia #Management #Algorithm #IDSA2019 #Guidelines #Inpatient
Management Algorithm - IDSA ... 2019 Guidelines ... Algorithm #IDSA2019 #Guidelines ... #Inpatient #HAP ... #HCAP #Treatment
IDSA Risk Factors for Multidrug-Resistant Pathogens 

#Diagnosis #Management #InfectiousDiseases #MDRO #RiskFactors #HAP #VAP #HCAP #IDSA2016 #Guidelines
IDSA Risk Factors ... #RiskFactors #HAP ... #VAP #HCAP #IDSA2016 ... #Guidelines #Pneumonia
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Community-Acquired Pneumonia (CAP ... fluoroquinolone #IDSA ... #Outpatient #CAP ... Regimen #Management #Guidelines
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
Guidelines for Perioperative ... Elective Total Hip ... perioperative #guidelines ... #pharmacology #table
IDSA 2017 CDiff Guidelines - Table 1. Recommendations for the Treatment of Clostridium difficile Infection in Adults

#Management
IDSA 2017 CDiff ... Guidelines - Table ... CDifficile #IDSA2017 #Guidelines
IDSA 2017 CDiff Guidelines - Table 2. Recommendations for the Treatment of Clostridium difficile Infection in Children

#Management
IDSA 2017 CDiff ... Guidelines - Table ... CDifficile #IDSA2017 #Guidelines
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 Guideline ... Dosing: 250 mcg tablet ... 2019 COPD GOLD guidelines ... exacerbations. 2019 GOLD guidelines ... eosinophils <100 and has
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table